C-Myb interacts with the glucocorticoid receptor and regulates its level in pre-B-acute lymphoblastic leukemia cells

Molecular and Cellular Endocrinology

Volumn 361, Issue 1-2, 2012, Pages 124-132

  Sarvaiya, Purvaba J ^a   Schwartz, Jason R ^a   Geng, Chuan dong ^a   Vedeckis, Wayne V ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lymphoblastic leukemia; Auto upregulation; C Myb; Glucocorticoid receptor

Indexed keywords

GLUCOCORTICOID RECEPTOR; PROTEIN C MYB;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; LEUKEMIA CELL; LYMPHOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; DEXAMETHASONE; DOXYCYCLINE; GENE EXPRESSION REGULATION, LEUKEMIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYB; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; STEROIDS; UP-REGULATION;

EID: 84864364323     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.03.024     Document Type: Article

References (38)

1. Adcock I.M. Molecular mechanisms of glucocorticosteroid actions. Pulm. Pharmacol. Ther. 2000, 13:115-126.
2. Anfossi G., Gewirtz A.M., Calabretta B. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc. Natl. Acad. Sci. USA 1989, 86:3379-3383.
3. Ashraf J., Kunapuli S., Chilton D., Thompson E.B. Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells. J. Steroid. Biochem. Mol. Biol. 1991, 38:561-568.
4. Bamberger C.M., Schulte H.M., Chrousos G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 1996, 17:245-261.
5. Caracciolo D., Venturelli D., Valtieri M., Peschle C., Gewirtz A.M., Calabretta B. Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis. J. Clin. Invest. 1990, 85:55-61.
6. Emambokus N., Vegiopoulos A., Harman B., Jenkinson E., Anderson G., Frampton J. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. Embo. J. 2003, 22:4478-4488.
7. Geng C.D., Schwartz J.R., Vedeckis W.V. A conserved molecular mechanism is responsible for the auto-up-regulation of glucocorticoid receptor gene promoters. Mol. Endocrinol. 2008, 22:2624-2642.
8. Geng C.D., Vedeckis W.V. A new, lineage specific, autoup-regulation mechanism for human glucocorticoid receptor gene expression in 697 pre-B-acute lymphoblastic leukemia cells. Mol. Endocrinol. 2011, 25:44-57.
9. Geng C.D., Vedeckis W.V. C-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter. J. Biol. Chem. 2005, 280:43264-43271.
10. Gewirtz A.M., Anfossi G., Venturelli D., Valpreda S., Sims R., Calabretta B. G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science 1989, 245:180-183.
11. Gewirtz A.M., Calabretta B. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 1988, 242:1303-1306.
12. Gross K.L., Cidlowski J.A. Tissue-specific glucocorticoid action: a family affair. Trends Endocrinol. Metab. 2008, 19:331-339.
13. Hongo T., Yajima S., Sakurai M., Horikoshi Y., Hanada R. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood 1997, 89:2959-2965.
14. Housley P.R., Forsthoefel A.M. Isolation and characterization of a mouse L cell variant deficient in glucocorticoid receptors. Biochem. Biophys. Res. Commun. 1989, 164:480-487.
15. Kaspers, G.J., Pieters, R., Van Zantwijk, C.H., Van Wering, E.R., Van Der Does-Van Den Berg, A., Veerman, A.J., 1998. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs, Blood 92, 259-266.
16. Kaspers, G.J., Veerman, A.J., Pieters, R., Van Zantwijk, C.H., Smets, L.A., Van Wering, E.R., Van Der Does-Van Den Berg, A., 1997. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia, Blood 90, 2723-2729.
17. Keith B.D. Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy. BMC Can. 2008, 8:84.
18. Klempnauer K.H., Gonda T.J., Bishop J.M. Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell 1982, 31:453-463.
19. Klumper E., Pieters R., Veerman A.J., Huismans D.R., Loonen A.H., Hahlen K., Kaspers G.J., van Wering E.R., Hartmann R., Henze G. In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood 1995, 86:3861-3868.
20. Kofler R., Schmidt S., Kofler A., Ausserlechner M.J. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J. Endocrinol. 2003, 178:19-27.
21. Leprince D., Gegonne A., Coll J., de Taisne C., Schneeberger A., Lagrou C., Stehelin D. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 1983, 306:395-397.
22. Lieu Y.K., Kumar A., Pajerowski A.G., Rogers T.J., Reddy E.P. Requirement of c-myb in T cell development and in mature T cell function. Proc. Natl. Acad. Sci. USA 2004, 101:14853-14858.
23. Miller A.L., Garza A.S., Johnson B.H., Thompson E.B. Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells. Can. Cell Int. 2007, 7:3.
24. Nakata Y., Shetzline S., Sakashita C., Kalota A., Rallapalli R., Rudnick S.I., Zhang Y., Emerson S.G., Gewirtz A.M. C-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression. Mol. Cell. Biol. 2007, 27:2048-2058.
25. Nanni P., Nicoletti G., Prodi G., Galli M.C., De Giovanni C., Grilli S., Lollini P.L., Gobbi M., Cavo M., Tura S. Glucocorticoid receptor and in vitro sensitivity to steroid hormones in human lymphoproliferative diseases and myeloid leukemia. Cancer 1982, 49:623-632.
26. Oh I.H., Reddy E.P. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 1999, 18:3017-3033.
27. Pedersen K.B., Vedeckis W.V. Quantification and glucocorticoid regulation of glucocorticoid receptor transcripts in two human leukemic cell lines. Biochemistry 2003, 42:10978-10990.
28. Pieters, R., Huismans, D.R., Loonen, A.H., Hahlen, K., van der Does-van den Berg, A., van Wering, E.R., Veerman, A.J., 1991. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia, Lancet 338, 399-403.
29. Pui C.H., Robison L.L., Look A.T. Acute lymphoblastic leukaemia. Lancet 2008, 371:1030-1043.
30. Ramdas J., Liu W., Harmon J.M. Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells. Can. Res. 1999, 59:1378-1385.
31. Riml S., Schmidt S., Ausserlechner M.J., Geley S., Kofler R. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells. Cell Death Differ. 2004, 11(Suppl. 1):S65-S72.
32. Schwartz J.R., Sarvaiya P.J., Vedeckis W.V. Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia. Mol. Cell. Endocrinol. 2010, 320:76-86.
33. Spokoini R., Kfir-Erenfeld S., Yefenof E., Sionov R.V. Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis. Mol. Endocrinol. 2010, 24:1136-1150.
34. Thomas M.D., Kremer C.S., Ravichandran K.S., Rajewsky K., Bender T.P. C-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 2005, 23:275-286.
35. Vegiopoulos A., Garcia P., Emambokus N., Frampton J. Coordination of erythropoiesis by the transcription factor c-Myb. Blood 2006, 107:4703-4710.
36. Webster J.C., Cidlowski J.A. Mechanisms of glucocorticoid-receptor-mediated repression of gene expression. Trends Endocrinol. Metab. 1999, 10:396-402.
37. Weston K. Myb proteins in life, death and differentiation. Curr. Opin. Genet. Dev. 1998, 8:76-81.
38. Xiao C., Calado D.P., Galler G., Thai T.H., Patterson H.C., Wang J., Rajewsky N., Bender T.P., Rajewsky K. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131:146-159.